TYME Technologies Inc

TYME Technologies Inc TYME is delivering scientific solutions without compromise.

TYME Technologies Inc., (Nasdaq: TYME), an innovative biotechnology company leveraging novel and data-driven approaches to develop therapeutics for difficult to treat cancers.

12/22/2021

We Want To Wish You A Wonderful Holiday Season and a Happy New Year!

đź“Ł Update: TYME announces additional encouraging preclinical data on the effect of TYME-19 in SARS CoV-2 infections. ...
12/14/2021

đź“Ł Update: TYME announces additional encouraging preclinical data on the effect of TYME-19 in SARS CoV-2 infections. Learn More: https://bit.ly/TYME19Update

TYME oral SM-88 poster accepted for presentation at American Society of Clinical Oncology Symposium. “Oral SM-88 p...
12/09/2021

TYME oral SM-88 poster accepted for presentation at American Society of Clinical Oncology Symposium. “Oral SM-88 plus MPS, an effective yet less toxic treatment option in second-line advanced ? Final phase II/III study results.”

https://bit.ly/ASCO2022

NOW ENROLLING: Pancreatic Cancer Action Network trial for patients. đź’ś
11/30/2021

NOW ENROLLING: Pancreatic Cancer Action Network trial for patients. đź’ś

A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer - Full Text View.

from our at TYME to yours.
11/25/2021

from our at TYME to yours.

Did you know? Symptoms of are hard to spot - and can even be mistaken for the common health condition heartburn. ...
11/22/2021

Did you know? Symptoms of are hard to spot - and can even be mistaken for the common health condition heartburn.


https://tymetrials.com

11/10/2021

It’s TYME to conquer ! We have partnered with to create the PanCAN trial for pancreatic cancer patients.

Address

1 Pluckemin Way, Suite 103
Bedminster, NJ
07921

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

(212) 461-2315

Website

Alerts

Be the first to know and let us send you an email when TYME Technologies Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to TYME Technologies Inc:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

TYME to conquer advanced cancers

TYME Technologies Inc., is an emerging biotechnology company focused on exploring novel therapeutic approaches designed to target cancer’s unique metabolism. Our mission at TYME is to develop innovative, transformational therapies that create better overall outcomes for patients and reduce the burden on healthcare resources.

While cancer survival rates have improved steadily since the 1970s, much more progress is needed. This year alone, cancer will strike nearly 1.8 million Americans and an estimated 18.1 million people worldwide. And because close to 610,000 people in the United States, and nearly 9.6 million worldwide are expected to die of cancer this year, TYME and its employees are working relentlessly to discover, develop and deliver innovative disease-altering medicines. Our goal is to transform certain advanced and difficult-to-treat cancers into diseases that are either curable or that can be managed as chronic conditions so that cancer patients can lead longer and better-quality lives.

Today, many cancers are treated with complex regimens and supportive care that are burdensome to the healthcare system and often difficult for patients to endure. At TYME, we are applying the latest advances in the field of cancer metabolism to develop novel Cancer Metabolism-Based Therapies (CMBTs™) that target the mechanisms of disease at their source, and thereby create significantly improved outcomes for patients.